Alex Dixon is Senior Analyst, Market Access & Analytics, at Magnolia Market Access. He has two years of consulting experience in the life sciences spanning market access, policy, commercial, and medical affairs.
Alex is driven by expanding patient access and affordability of life-changing therapies. Prior to joining Magnolia, Alex was a Senior Analyst at Magnolia’s sister company, 81qd, where he supported analytics workstreams for a variety of clinical and commercial-stage pharmaceutical manufacturers ranging from KOL identification to clinical trial recruitment exercises.
Alex received his Bachelor of Science in biochemistry and chemical biology from Vanderbilt University.